Metraipolis › archive › dc_ca9be2dbc65d

Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models — Europe PMC PMID:42317369

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42317369
DOI: 10.3389/fimmu.2026.1850760
License (as archived): solo-consultazione
Archived: 2026-10-31T18:49:12.472Z
SHA-256 of the archived text: 4f18802417e401a6f3399148db8f2cf7622f2e05324d2c0f97b7ba6c0a8bb268
Stable URL of this page: https://metraipolis.com/documento/dc_ca9be2dbc65d

How to cite

Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models — Europe PMC PMID:42317369 — Europe PMC (en), https://europepmc.org/article/MED/42317369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca9be2dbc65d (Metraipolis archive dc_ca9be2dbc65d, sha256 4f18802417e401a6f3399148db8f2cf7622f2e05324d2c0f97b7ba6c0a8bb268)

BibTeX

@misc{dcca9be2dbc65d,
  title = {Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models — Europe PMC PMID:42317369},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317369},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca9be2dbc65d; sha256 4f18802417e401a6f3399148db8f2cf7622f2e05324d2c0f97b7ba6c0a8bb268},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317369. Agents can read the archived copy with the MCP tool read_document.